Showing results (61-70 of 162) with videos related to
Sort By:
Pageof 17
The Journal of Pathology|February 22, 2023
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesisArne Van der Vreken, Inge Oudaert, Gamze Ates, et al.Journal of Experimental & Clinical Cancer Research : CR|May 4, 2026
IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myelomaHatice Satilmis, Adrien Denis, Emma Verheye, et al.Oncotarget|June 2, 2018
Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cellsNathan De Beule, Eline Menu, Mathieu J M Bertrand, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2012
The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllinMiguel Lemaire, Charlotte Fristedt, Prasoon Agarwal, et al.International Journal of Cancer|June 5, 2007
Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survivalEline Menu, Helena Jernberg-Wiklund, Hendrik De Raeve, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2016
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary InvolvementLeo Rasche, Emmanuelle Menoret, Valentina Dubljevic, et al.Haematologica|April 22, 2006
The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM modelEline Menu, Kewal Asosingh, Stefano Indraccolo, et al.Hemasphere|August 20, 2025
Syntenin inhibition impairs stroma-tumor communication in multiple myeloma and improves bortezomib treatment efficiencyChenggong Tu, Raphael Leblanc, Arne Van der Vreken, et al.The Journal of Pathology|December 16, 2016
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activationNathan De Beule, Kim De Veirman, Ken Maes, et al.Cancers|November 24, 2019
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple MyelomaSylvia Faict, Inge Oudaert, Ludovic D'Auria, et al.Pageof 17